Solopharm received two awards at the XII Pharmaceutical Award «Green Cross», the award ceremony of which took place on June 26 in Saint Petersburg as part of the XXVIII Green Cross Conference.
Based on the results of a two-stage expert council vote, Atrevozol® was named the winner in the nomination «Product №1 for Anxiety and Stress», while the educational portal IQ Provision was recognized as «Educational Portal №1 for the Pharmaceutical Community».
The Green Cross Award is one of the most prestigious professional honors in Russia’s pharmacy sector. Winners are determined through a two-stage voting process involving over 1 500 members of the expert council-heads of pharmacy chains, pharmaceutical companies, distributors, analytical organizations, and other industry participants. This format ensures objective assessment of products, companies, and projects that have earned the highest recognition from the professional community.
The victory of Atrevozol® confirms the high regard for the drug among pharmacy market professionals. For Solopharm, this is a significant achievement, reflecting the company’s efforts to develop modern medicines that meet the current needs of patients and the medical community.
Equally important is the recognition of the educational platform IQ Provision, which for many years has helped pharmacists and pharmaceutical specialists enhance their professional qualifications, gain up-to-date knowledge about modern drugs, clinical guidelines, and the nuances of pharmaceutical counseling. Today, the portal unites thousands of specialists across the country and is one of the largest educational platforms for the pharmacy community.
Comment from the Solopharm Press Office:
«It is especially valuable for us that both awards are recognition from the professional community. The victory of Atrevozol® confirms the trust specialists place in our drugs, and the recognition of IQ Provision reflects the high demand for the company’s educational initiatives. We thank the award organizers, the expert council, and all voters for their trust. This recognition inspires us to continue developing innovative medicines, advancing professional education, and supporting the pharmaceutical community».
Solopharm congratulates the teams involved in the development, promotion, and growth of Atrevozol®, as well as the IQ Provision team. This victory is the result of collaborative work by specialists from various fields, united by a common goal – to create high-quality solutions for professional development in the industry and for safeguarding people’s health.